NCT03462498View on ClinicalTrials.gov

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

3,008

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

March 31, 2026

Conditions
Acute Coronary SyndromeAcute Myocardial InfarctionCoronary Artery DiseasePercutaneous Coronary InterventionPlatelet Aggregation Inhibitors
Interventions
DRUG

1-months DAPT

1-month DAPT followed by 59-month monotherapy

DRUG

12-month DAPT

12-month DAPT followed by 48-month monotherapy

Trial Locations (1)

606-8507

Kyoto University Graduate School of Medicine, Kyoto

All Listed Sponsors
lead

Kyoto University, Graduate School of Medicine

OTHER